These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1135 related items for PubMed ID: 18815880

  • 1. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R, Viehl CT, Oertli D.
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [Abstract] [Full Text] [Related]

  • 2. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H.
    Cancer; 2006 Jan 01; 106(1):35-41. PubMed ID: 16333848
    [Abstract] [Full Text] [Related]

  • 3. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 4. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Rudloff U, Brogi E, Brockway JP, Goldberg JI, Cranor M, Wynveen CA, Nehhozina T, Reiner AS, Patil S, Van Zee KJ.
    Cancer; 2009 Mar 15; 115(6):1203-14. PubMed ID: 19170233
    [Abstract] [Full Text] [Related]

  • 5. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 6. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F.
    Cancer; 2005 Jul 01; 104(1):20-9. PubMed ID: 15912514
    [Abstract] [Full Text] [Related]

  • 7. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.
    Strahlenther Onkol; 2004 Jan 01; 180(1):38-44. PubMed ID: 14704843
    [Abstract] [Full Text] [Related]

  • 8. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY.
    Cancer; 2004 May 01; 100(9):1823-32. PubMed ID: 15112262
    [Abstract] [Full Text] [Related]

  • 9. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
    Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F.
    Cancer; 2005 Aug 01; 104(3):479-90. PubMed ID: 15968686
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
    Hwang N, Schiller DE, Crystal P, Maki E, McCready DR.
    Ann Surg Oncol; 2009 Nov 01; 16(11):3000-9. PubMed ID: 19603233
    [Abstract] [Full Text] [Related]

  • 11. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK.
    Cancer; 2003 Feb 15; 97(4):926-33. PubMed ID: 12569592
    [Abstract] [Full Text] [Related]

  • 12. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J, Sulyok Z, Polgár C, Major T, Tóth J, Németh G.
    Magy Seb; 2001 Aug 15; 54(4):209-14. PubMed ID: 11550486
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.
    Cancer; 2004 Aug 01; 101(3):508-17. PubMed ID: 15274063
    [Abstract] [Full Text] [Related]

  • 14. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ, McCormick B, Recht A, Haffty BG, Taylor ME, Kuske RR, Bornstein BA, McNeese M, Schultz DJ, Fowble BL, Barrett W, Yeh IT, Kurtz JM, Amalric R, Fourquet A.
    Cancer J Sci Am; 1996 Aug 01; 2(3):158-65. PubMed ID: 9166516
    [Abstract] [Full Text] [Related]

  • 15. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ, Shin YD, Song YJ.
    World J Surg Oncol; 2016 Apr 27; 14():126. PubMed ID: 27122132
    [Abstract] [Full Text] [Related]

  • 16. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ.
    Cancer; 2001 Mar 15; 91(6):1090-7. PubMed ID: 11267953
    [Abstract] [Full Text] [Related]

  • 17. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S, Schwartz GF, Komarnicky L, Garcia-Young JA.
    Breast J; 2006 Mar 15; 12(2):159-64. PubMed ID: 16509842
    [Abstract] [Full Text] [Related]

  • 18. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK.
    Cancer; 2002 Nov 15; 95(10):2059-67. PubMed ID: 12412158
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy.
    Zhou P, Gautam S, Recht A.
    Breast Cancer Res Treat; 2007 Jan 15; 101(1):51-7. PubMed ID: 16821084
    [Abstract] [Full Text] [Related]

  • 20. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.